Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Filings indexed 326 across all filing types
Latest filing 2019-12-04 Major Shareholding Noti…
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity acquires or changes a significant stake (typically 5% or more) in a listed company. This specific document details the shareholding changes of KTB Network in the company 'Notus'. Since this is a mandatory regulatory disclosure regarding major shareholding thresholds, it falls under the 'Major Shareholding Notification' category.
2019-12-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the share ownership of major shareholders and special related parties, including their holdings, changes in ownership, and the purpose of holding (management influence). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2019-12-04 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the acquisition of shares by BNH Investment in the company 'Notus' (주)노터스. This type of filing is used to notify the market and regulators when an entity crosses a significant ownership threshold. In the provided classification schema, this falls under 'Major Shareholding Notification'.
2019-11-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. This type of filing is used to notify the regulatory authorities (Financial Services Commission and Korea Exchange) when an entity's shareholding in a listed company crosses certain thresholds. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2019-11-29 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a public offering, including subscription status, allocation, shareholding changes, and use of proceeds. This type of filing is a standard regulatory requirement following a capital raise and falls under the category of share issuance and capital changes.
2019-11-19 Korean
투자설명서
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a '투자설명서' (Investment Prospectus) for a public offering of shares by '주식회사 노터스' (KNOTUS Co., Ltd.). It contains detailed information regarding the offering, including the number of shares, price range, subscription period, and comprehensive risk factors (business and company risks). This is a formal regulatory document required for securities offerings, which falls under the category of a Prospectus/Information Statement for investors.
2019-11-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.